Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions
Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions have?
Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions published?
Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions has 2015 year in the ScholarIQ index.
What is the open-access status of Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions?
Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions has bronze oa status in the ScholarIQ index.
What is the DOI of Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions?
The DOI for Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions is on the source record.
What is the OpenAlex record for Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions?
The OpenAlex for Therapeutic Advantage of Intrabeam IORT for Treating Shallowly Populated Breast Cancer Lesions is on the source record.